Joseph Aisner

Rutgers, The State University of New Jersey

Papers

Total Citations

H-Index

About

Dr. Joseph Aisner is a distinguished oncologist and researcher whose work has significantly advanced the understanding and management of thoracic malignancies, particularly lung cancer. His key research areas encompass thoracic oncology, cancer chemotherapy, and the development of novel therapeutic strategies. Dr. Aisner is perhaps best known for his pioneering contributions to the study of small cell lung cancer (SCLC) and malignant mesothelioma, where his clinical trials helped establish foundational chemotherapy regimens that improved patient outcomes. His impact is reflected in his highly cited work, such as the 2019 study on paravertebral nerve blocks with liposomal bupivacaine for pain control following video-assisted thoracoscopic surgery and thoracotomy, which garnered 27 citations and highlighted his commitment to enhancing perioperative care. Beyond this, Dr. Aisner has authored numerous seminal papers on combination chemotherapy and supportive care in oncology, earning him a reputation as a leader in the field. His notable achievements include serving as a principal investigator for major cooperative group trials and mentoring a generation of oncologists. Dr. Aisner’s research continues to shape clinical practice, offering hope and improved quality of life for patients with thoracic cancers.